John T. Maxwell serves as Executive at Aquestive Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, John T. Maxwell has executed 6 insider transactions totaling $166.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 19, 2022 involved selling 74,456 shares valued at $62.5K.
John T. Maxwell currently holds 440,593 shares of Aquestive Therapeutics, Inc. (AQST), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John T. Maxwell has been a net buyer of AQST stock. They have purchased $142.3K and sold $24.0K worth of shares.
John T. Maxwell's most recent insider trade was on Nov 19, 2022, when they sold 74,456 shares at $0.84 per share.
Get notified when new Form 4 filings are submitted
| $1.36 |
| Discretionary |
| Jul 27, 2022 | WEJO | $50.0K | Award | 36,757 | $1.36 | Discretionary |
| Aug 18, 2020 | AQST | $24.0K | Sale | 3,000 | $8.00 | Discretionary |
| Dec 6, 2018 | AQST | $44.4K | Purchase | 5,000 | $8.87 | Discretionary |
| Nov 21, 2018 | AQST | $98.0K | Purchase | 10,000 | $9.80 | Discretionary |